O2− inhibits PP2A-mediated dephosphorylation of Bcl-2 at S70. (A-C) Lysates from DDC-treated Jurkat, Hela, and MDA231 were immunoprecipitated (IP) and immunoblotted (IB) using the indicated antibodies. Input refers to whole cell lysates that are not subjected to IP procedures. Immunoglobulin G (IgG) refers to untreated lysates that were incubated with nonspecific IgG primary antibodies. (D) Mitochondria isolated from MDA231 or Jurkat cells were incubated with proteinase K for 25 minutes followed by lysis and IB for the indicated proteins. As a control, incubation of mitochondria with Triton-X100 resulted in the digestion of SOD2 (matrix protein) and COX Va (inner mitochondrial membrane [IMM] protein). (E) Mitochondrial/cytosolic fractions from DDC-treated Jurkat or MDA231 cells (with or without tiron pretreatment) were IB for the indicated proteins. SOD1 was employed as a cytosolic marker, whereas prohibitin, an IMM protein, served as a mitochondrial marker. (F) Confocal fluorescence imaging studies of DDC-treated MDA231 cells. Colocalization of Bcl-2 (red) and PP2A-C (green) appears as yellow punctate (red arrows). (G) Confocal imaging of Jurkat cells 48 hours after silencing of SOD1. Selected cells were enlarged for greater clarity.